510(k) Report

510(k) · Cleared

Cleared

Immunocap Allergen D201, House Dust Mite, Model 4-4896-01

K092050510(k) TraditionalCleared Nov 20, 2009136-day reviewClass II21 CFR 866.5750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Phadia AB · DHB System, Test, Radioallergosorbent (Rast) Immunological

Cleared on Nov 20, 2009 as substantially equivalent to K051218 (Pharmacia Diagnostics AB, 2005) after a 136-day review. Its family tree reaches back 2 generations to 1996.

Decided
Nov 20, 2009
Review
136 days
Class
Class II
Product code
DHB
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K962274 (1996). No later device cites it as a predicate yet.

  1. Root · 2 generations backK962274 Unicap 100Pharmacia, Inc. · 1996
  2. 1 generation backK051218 Modification to: Unicap Specific IgePharmacia Diagnostics AB · 2005 · Recalled
  3. This deviceK092050 Immunocap Allergen D201, House Dust Mite, Model 4-4896-01Phadia AB · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K962274Unicap 100Pharmacia, Inc.1996—
−1K051218Modification to: Unicap Specific IgePharmacia Diagnostics AB20053
0 (this device)K092050Immunocap Allergen D201, House Dust Mite, Model 4-4896-01Phadia AB2009—
FIG. 1 — Lineage of K092050, 1996–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DHB device

  1. #1 K260331 IMMULITE 2000 3gAllergy Specific IgE Vantage…score 12.3 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051218Modification to: Unicap Specific IgePharmacia Diagnostics AB20053

Also cleared against K051218: 26 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 8.7 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 26 other devices also cite its predicate K051218.

How does its category compare?

All DHB devices

DHB System, Test, Radioallergosorbent (Rast) Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · DHB

2in 2025

2007: 12008: 22009: 72010: 32011: 52012: 32013: 52014: 12015: 12016: 22017: 12018: 22019: 32020: 22021: 12022: 22025: 22026 (partial year): 6
2007high 7 (2009) · low 0 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHB

90in 2019

2009: 118 days median2010: 247 days median2011: 405 days median2012: 260 days median2013: 257 days median2019: 90 days median2026 (partial year): 138 days median
2007high 405 (2011) · low 90 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DHB

14in 2025

2012: 12014: 12017: 12018: 12022: 32025: 14
2007high 14 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHB

6in 2025

2008: 12011: 12012: 22015: 12017: 112018: 62019: 42021: 72022: 12023: 62024: 102025: 6
2007high 11 (2017) · low 0 (2007)2025

MAUDE reports naming product code DHB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—01
2009711800
2010324700
2011540501
2012326012
2013525700
20141—10
20151—01
20162—00
20171—111
20182—16
201939004
20202—00
20211—07
20222—31
20230—06
20240—010
20252—146
202661380—

What is it indicated for?

ImmunoCAP Specific IgE Assay is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. 'ImmunoCAP Specific IgE is to be used with the instruments ImmunoCAP 100E, ImmunoCAP 250 and ImmunoCAP 1000. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings, and is to be used in clinical laboratories, as well as physician office laboratories.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092050: Immunocap Allergen D201, House Dust Mite, Model 4-4896-01.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K092050

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026